SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported): October 23, 2003
RESPIRONICS, INC.
(Exact name of Registrant as specified in its charter)
| Delaware (State or Other Jurisdiction of Incorporation) |
000-16723 (Commission File Number) |
25-1304989 (I.R.S. Employer Identification Number) |
| 1010 Murry Ridge Lane Murrysville, Pennsylvania (Address of Principal Executive Offices) |
15668-8525 (Zip Code) |
724-387-5200
(Registrant’s telephone number, including area code)
TABLE OF CONTENTS
| Page | ||
| 2 | ||
| 3 | ||
| 4 |
| Item 9. | REGULATION FD DISCLOSURE. |
The following information is furnished pursuant to Item 12, “Disclosure of Results of Operations and Financial Condition.”
On October 23, 2003, Respironics, Inc. issued a press release announcing its financial results for the three months ended September 30, 2003. A copy of the press release is attached hereto as Exhibit 99.
Exhibits
| 99 | Press release dated October 23, 2003 issued by Respironics, Inc. |
2
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| RESPIRONICS, INC. | ||
| By: | /s/ Daniel J. Bevevino | |
| Daniel J. Bevevino Vice President, and Chief Financial and Principal Accounting Officer | ||
Dated: October 23, 2003
3
| Exhibit No. |
Description | |
| 99 |
Press release, dated October 23, 2003, issued by Respironics, Inc. |
4